Delivering Safe, Trustworthy Medicines for Children ーInside SHIONOGI’s RSV Drug Discoveryー Oct.28, 2025 Research
Taking on the Challenge of Untreatable Conditions: Toward a “Future of Hearing” Through Drug Discovery Oct.08, 2025 Research
The Power to Create Medicines That Reach Patients—Passing SHIONOGI’s Baton of Innovation to the Next Generation Oct.08, 2025 Research
Facing Patients Beyond Prescriptions: The Mission and Challenges of the Frontline Medical Information Center Jun.04, 2024 MR
Merging with the US biotech venture Qpex: A chronicle of striving for the integration process aimed at maximizing value Apr.16, 2024 Corporate
Striving for Palliative Care that Leaves No One Behind: Aiming for a Communication Barrier-Free Reality Apr.03, 2024 MR
SHIONOGI’s Commitment to Antibiotics: Aiming for an Ideal Collaboration between Industry, Government, and Academia to Tackle Infectious Diseases Apr.03, 2024 Corporate
Embracing the Challenge of Societal “Issues”: A Young Challenger Looks Beyond the Walls Mar.05, 2024 New Business
Leveraging Real-world Data and Artificial Intelligence: The Story Behind the Outstanding Leadership Award Mar.05, 2024 DX
Researchers on One Health and the Proper Use of Medications: Behind the Scenes of Rare Species Conservation and Infectious Disease Control Feb.22, 2024 Research